PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS, CONTAINING POLYSACCHARIDE EXTRACTED FROM PHELLINUS LINTEUS

From the paper

Abstract

PURPOSE: A pharmaceutical composition containing polysaccharide such as galactomannoglucan extracted from the mycelium of Phellinus linteus as an effective ingredient is provided. The composition can be used for treatment of arthritis, diabetic retinopathy, psoriasis, cancer or the like.

CONSTITUTION: The pharmaceutical composition for prevention and treatment of diseases associated with angiogenesis contains 80 to 95% by weight of galactomannoglucan as an effective ingredient. The galactomannoglucan is obtained from the mycelium of Phellinus linteus. The effective amount of the pharmaceutical composition is 50 to 80mg/kg, preferably 55 to 65mg/kg and can be administered 1 to 3 times per day. The disease associated with angiogenesis is arthritis, proriasis, cancer and ophthalmic disease selected from diabetic retinopathy, macular degeneration, retinopathy of prematurity and neovascular glaucoma.